Current Cancer Therapy Reviews

Editor-in-Chief

Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Shatin
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 2, May

Dedication to Professor Tony Dodi

Volume:4   Issue: 2
Pp: i-i

DOI: 10.2174/157339408784310106
Published on: 01 March, 2012

Editorial [Hot Topic: Cancer Biomarkers Guest Editor: Robert C. Rees]

Volume:4   Issue: 2
Pp: 77-78
Robert C. Rees
DOI: 10.2174/157339408784310124
Published on: 01 March, 2012

Emerging Breast Cancer Biomarkers

Volume:4   Issue: 2
Pp: 79-85
Stephanie A. Laversin, Amanda K. Miles, Graham R. Ball and Robert C. Rees
DOI: 10.2174/157339408784310179
Published on: 01 March, 2012

Overview of Prostate Biomarkers as Potential Targets for Immunotherapy

Volume:4   Issue: 2
Pp: 86-95
Amanda K. Miles, Alistair Roger, Richard Parkinson, Robert C. Rees and Stephanie E.B. McArdle
DOI: 10.2174/157339408784310034
Published on: 01 March, 2012

Prognostic Biomarkers of Cutaneous Malignancies – Serological, Immunohistochemical and Proteomic Approaches

Volume:4   Issue: 2
Pp: 96-104
Dirk Schadendorf, Jochen Utikal, Balwir Matharoo-Ball, Robert C. Rees and Selma Ugurel
DOI: 10.2174/157339408784310061
Published on: 01 March, 2012

HLA Class I Expression, Tumor Escape and Cancer Progression

Volume:4   Issue: 2
Pp: 105-110
Natalia Aptsiauri, Teresa Cabrera, Angel Garcia Lora, Francisco Ruiz-Cabello and Federico Garrido
DOI: 10.2174/157339408784310052
Published on: 01 March, 2012

Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders

Volume:4   Issue: 2
Pp: 111-119
Evelyna Derhovanessian, Cecile Gouttefangeas, Sven Koch and Graham Pawelec
DOI: 10.2174/157339408784310151
Published on: 01 March, 2012

NK Cell, Monocyte and Non T Cell Biomarkers as Prognostic Indicators in Cancer Immunotherapy

Volume:4   Issue: 2
Pp: 120-124
Renu Datta, Catherine L. Riley, Italo A. Dodi and Robert C. Rees
DOI: 10.2174/157339408784310133
Published on: 01 March, 2012

Lymphocyte Biomarkers of Clinical Responses to Adoptive Immunotherapy of Malignant Melanoma

Volume:4   Issue: 2
Pp: 125-129
Nathalie Labarriere, Brigitte Dreno and Francine Jotereau
DOI: 10.2174/157339408784310142
Published on: 01 March, 2012

NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies

Volume:4   Issue: 2
Pp: 130-136
Anastassia Mihaylova, Snejina Mihailova and Elissaveta Naumova
DOI: 10.2174/157339408784310070
Published on: 01 March, 2012

Application of Proteomics to the Discovery of Cancer Biomarkers

Volume:4   Issue: 2
Pp: 137-143
Murrium Ahmad and Balwir Matharoo-Ball
DOI: 10.2174/157339408784310089
Published on: 01 March, 2012

Protein Glycosylation as Marker of Melanoma Progression

Volume:4   Issue: 2
Pp: 144-148
Anna Litynska, Malgorzata Przybylo, Dorota Hoja-Lukowicz, Ewa Pochec, Marcelina Kremser, Dorota Ciolczyk-Wierzbicka, Maria Labedz and Piotr Laidler
DOI: 10.2174/157339408784310115
Published on: 01 March, 2012

Autoantibody Profiles as Biomarkers for Response to Therapy and Early Detection of Cancer

Volume:4   Issue: 2
Pp: 149-156
Zane Kalnina, Karina Silina and Aija Line
DOI: 10.2174/157339408784310160
Published on: 01 March, 2012

Computational & Statistical Methodologies to Identify Biomarkers in Cancer

Volume:4   Issue: 2
Pp: 157-160
Graham R. Ball
DOI: 10.2174/157339408784310043
Published on: 01 March, 2012

Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines

Volume:4   Issue: 2
Pp: 161-165
Angus G. Dalgleish
DOI: 10.2174/157339408784310098
Published on: 01 March, 2012